European Flow Cytometry Market Examined in New Research Study Recently Published at MarketPublishers.com
21 Mar 2012 • by Natalie Aster
LONDON – During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the flow cytometry markets worldwide.
Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
New market report "The 2012 European Flow Cytometry Market: France, Germany, Italy, Spain, UK - Emerging Opportunities and Business Expansion Strategies" worked out by Venture Planning Group offers truly insightful information on the market, including test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of leading instrument and reagents suppliers.
The report examines future marketing and technological trends in France, Germany, Italy, Spain, and the UK; provides market share estimates, test volume forecasts, and instrument placements; compares features of major clinical and research flow cytometers; profiles competitors and emerging market entrants; and suggests specific product and marketing opportunities for flow cytometry instruments and reagents.
Title: The 2012 European Flow Cytometry Market: France, Germany, Italy, Spain, UK - Emerging Opportunities and Business Expansion Strategies
Published: March, 2012
Price: US$ 12,500
More new market research reports by the publisher can be found at Venture Planning Group page.
The Market Publishers, Ltd.
Mrs. Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970